Necrotising polyarteritis complicating rheumatoid arthritis (RA) is an infrequent but potentially lethal extra-articular manifestation of the disease. Patients who develop this complication have immunological abnormalities, including high titres of serum antiimmunoglobulin G (IgG) antibody (rheumatoid factor), antinuclear antibodies (ANA), and reduced levels of complement (Morgan et al., 1969) . Here we report the case of a patient with long standing seropositive RA who developed necrotising polyarteritis. Serial serological observations made before, during, and after the development of the arteritis indicated that the onset of vasculitis was associated with high levels of circulating immune complexes and low levels of circulating complement. The clearance kinetics of the complexes from his circulation after the institution of adrenocorticosteroid therapy suggested that the antibody responsible for the arteritis-inducing complex was of the IgG class.
Materials and methods
The Clq binding activity (ClqBA) was determined using a modified radioimmunoassay (Zubler et al., 1976 , Rossen et al., 1977 . Serum anti-IgG antibody was measured by the latex agglutination method (Singer and Plotz, 1956 (Person et al., 1974 ). Serum cryoglobulins were tested for by using microcapillary tubes. An indirect immunofluorescence procedure utilising a dipteran trypanosome, Crithidia luciliae, as substrate was used to detect antibody to native DNA (Person et al., 1975 (Volweiler et al., 1955) . This response of the immune of lgG synthesis by methylprednisolone (Butler and Rossen, 1973) . The data are compatible with the antibody involved being of the IgG class and capable of fixing complement. We know much less about the putative antigen. Several possibilities known to be sometimes associated with immune complex disease have been ruled out. These would include cold reactive IgM anti-IgG seen in mixed cryoglobulinaemia (negative cryoglobulins); HB, antigenaemia-associated polyarteritis nodosa (negative HB,AG); and, at least by inference, DNA-anti-DNA as seenj in systemic lupus erythematosus (negative anti-DNA antibody). We are currently analysing the patient's sera for other possible antigens. The changing antinuclear antibody pattern bears mention in this regard ( Table 1 ). The loss of antinucleolar reactivity in the serum from April 1974 and its reappearance in February 1977 after 5 weeks of glucocorticoid therapy might suggest that RNA was involved in the complex. Antinucleolar antibody is thought to be specific for antibody to RNA or an RNA precursor (Pinnas et al., 1973) , and its absence during that period might suggest that circulating RNA and antibody to RNA were complexed in equilibrium.
Other materials, such as low molecular weight IgM or IgG rheumatoid factor, could conceivably participate in the toxic complex.
Finally, when the steroid dose was reduced, the arteritis was no longer suppressed and the patient's condition was exacerbated both clinically and serologically. Suppression of the vasculitis was eventually achieved with the use of cyclophosphamide.
We believe that the serial analysis of immunological events in this case has provided greater insight into the immunopathological events which occur during the development of rheumatoid vasculitis.
